7KM5

Crystal structure of SARS-CoV-2 RBD complexed with Nanosota-1

Summary for 7KM5

• Entry DOI: 10.2210/pdb7km5/pdb
• Descriptor: Spike protein S1, nanobody, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (4 entities in total)
• Functional Keywords: rbd, nanobody, viral protein, viral protein-immune system complex, viral protein/immune system
• Biological source: Severe acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2, COVID-19 virus); More
• Total number of polymer chains: 4
• Total formula weight: 79089.59

Authors

Ye, G.,Shi, K.,Aihara, H.,Li, F. (deposition date: 2020-11-02, release date: 2021-08-04, Last modification date: 2023-10-18)

• Primary citation: Ye, G.,Gallant, J.,Zheng, J.,Massey, C.,Shi, K.,Tai, W.,Odle, A.,Vickers, M.,Shang, J.,Wan, Y.,Du, L.,Aihara, H.,Perlman, S.,LeBeau, A.,Li, F.; The development of Nanosota - 1 as anti-SARS-CoV-2 nanobody drug candidates.; Elife, 10:-, 2021; PubMed: 34338634; DOI: 10.7554/eLife.64815

Experimental method

X-RAY DIFFRACTION (3.19 Å)